Browse Category

NYSE:FRMI.O News 7 January 2026

Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

Fermi Inc stock slides 10% on fresh class-action filing headlines, with Evercore conference next

New York, January 7, 2026, 13:24 (EST) — Regular session Shares of Fermi Inc (FRMI.O) slid on Wednesday, last down $1.01, or about 10.6%, at $8.50. The stock hit an intraday low of $8.37 and had traded about 5.6 million shares. The move came as plaintiffs’ firms pushed fresh notices around a proposed securities class action lawsuit, reopening questions about…

Stock Market Today

  • Teva Pharmaceutical Industries: Assessing Value After 79% One-Year Surge
    January 29, 2026, 3:52 PM EST. Teva Pharmaceutical Industries (TEVA) shares have jumped 79.1% over the past year, raising questions about current valuation at around $33.21. Despite the price rally, a Discounted Cash Flow (DCF) analysis indicates the stock trades at roughly 49.1% below its intrinsic value estimate of $65.20 per share, suggesting it remains undervalued. TEVA's latest twelve-month free cash flow stood at $1.12 billion, with analysts projecting growth to $4.58 billion by 2030. The company scored 2 out of 6 in Simply Wall St's valuation check, signaling some caution. This data provides investors a mixed picture: strong recent gains tempered by underlying value metrics pointing to potential investment opportunity in this large generic and specialty pharmaceutical firm.
Go toTop